stub The Endocannabinoid System is More Than Just CB1 & CB2 Receptors - MyCannabis.com
Connect with us

Health

The Endocannabinoid System is More Than Just CB1 & CB2 Receptors

mm

Published

 on

You might have heard about the Endocannabinoid System (ECS) and its key players, CB1 and CB2 receptors, but there's so much more to the story! Recent research has revealed a whole new cast of characters in the ECS family, making it even more fascinating.

Read about the roles of the endocannabinoid system.

Introducing GPR-55, TRPV1, and PPARs!

In addition to CB1 and CB2 receptors, the ECS now includes other receptors like GPR-55, TRPV1, and PPARs. They play important roles alongside CB1 and CB2 receptors, responding to various substances in our bodies.

One such substance is Anandamide, which interacts with these receptors. But it's not the only one! There are also other lipid-based substances known as N-acylethanolamines and N-acyl-dopamines that these receptors respond to.

Even certain saturated fatty acids like PEA, OEA, SEA, and LEA have their own special functions within the ECS. While they don't target CB1 or CB2 receptors, they act as powerful allies for PPAR and GPR-55. Not only that, they boost the activity of Anandamide, making the ECS even more complex and intriguing!

With these new discoveries, scientists are now exploring lesser-known “orphan” G protein-coupled receptors (GPCRs) that are part of the ECS. These receptors have not received much attention in the past, but they deserve recognition within the expanded endocannabinoid system – the #endocannabinoidome!

It's absolutely mind-blowing to witness how our understanding of the endocannabinoid system is rapidly evolving!

By broadening the definition of the ECS, countless new possibilities for research and potential therapies are unfolding. Who knows what other amazing discoveries await us in this captivating realm of science?! The potential benefits for our health and well-being are incredibly exciting!

As researchers dive deeper into the complexities of the endocannabinoidome, we can look forward to more breakthroughs that may revolutionize medicine and open doors to novel treatments for various conditions. Whether it's managing pain, promoting relaxation, or enhancing our overall wellness, the ECS holds a treasure trove of opportunities.

Moving Beyond CB1 & CB2

So, the next time you hear about the Endocannabinoid System, remember that it's not just about CB1 and CB2 receptors. There's a whole family of receptors and lipid-based substances working together to keep our bodies in balance. It's a captivating journey of discovery, and we are just beginning to scratch the surface!

Let's keep our eyes wide open and eagerly await what the future holds for the ever-evolving and awe-inspiring Endocannabinoid System! 

 

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.